A detailed history of Sompo Asset Management Co., Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sompo Asset Management Co., Ltd. holds 49,780 shares of BMY stock, worth $2.93 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
49,780
Previous 34,640 43.71%
Holding current value
$2.93 Million
Previous $1.44 Million 79.14%
% of portfolio
0.41%
Previous 0.24%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $600,452 - $783,495
15,140 Added 43.71%
49,780 $2.58 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $116,725 - $153,671
-2,900 Reduced 7.73%
34,640 $1.44 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $40,783 - $46,240
850 Added 2.32%
37,540 $2.04 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $31,996 - $38,181
660 Added 1.83%
36,690 $1.88 Million
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $2.19 Million - $2.45 Million
-37,790 Reduced 51.19%
36,030 $2.09 Million
Q2 2023

Aug 10, 2023

BUY
$63.71 - $70.74 $426,857 - $473,957
6,700 Added 9.98%
73,820 $4.72 Million
Q1 2023

May 09, 2023

SELL
$65.71 - $74.53 $71,623 - $81,237
-1,090 Reduced 1.6%
67,120 $4.65 Million
Q4 2022

Feb 01, 2023

BUY
$68.48 - $81.09 $115,731 - $137,042
1,690 Added 2.54%
68,210 $4.91 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $2,159 - $1.28 Million
-16,610 Reduced 19.98%
66,520 $4.73 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $1.62 Million - $1.78 Million
-22,300 Reduced 21.15%
83,130 $6.4 Million
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $41,806 - $50,129
680 Added 0.65%
105,430 $7.7 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $1.59 Million - $1.85 Million
29,590 Added 39.37%
104,750 $6.53 Million
Q3 2021

Nov 09, 2021

BUY
$59.17 - $69.31 $2.37 Million - $2.78 Million
40,070 Added 114.19%
75,160 $4.45 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $219,161 - $238,666
3,540 Added 11.22%
35,090 $2.35 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $2.27 Million - $2.55 Million
-38,200 Reduced 54.77%
31,550 $1.99 Million
Q4 2020

Feb 08, 2021

BUY
$57.74 - $65.43 $31,757 - $35,986
550 Added 0.79%
69,750 $4.33 Million
Q3 2020

Nov 06, 2020

BUY
$57.43 - $63.64 $20,674 - $22,910
360 Added 0.52%
69,200 $4.17 Million
Q2 2020

Aug 05, 2020

SELL
$54.82 - $64.09 $718,690 - $840,219
-13,110 Reduced 16.0%
68,840 $4.05 Million
Q1 2020

May 11, 2020

SELL
$46.4 - $67.43 $2 Million - $2.9 Million
-43,030 Reduced 34.43%
81,950 $4.57 Million
Q4 2019

Feb 10, 2020

SELL
$49.21 - $64.19 $211,110 - $275,375
-4,290 Reduced 3.32%
124,980 $8.02 Million
Q3 2019

Nov 01, 2019

BUY
$42.77 - $50.71 $531,203 - $629,818
12,420 Added 10.63%
129,270 $6.56 Million
Q2 2019

Aug 02, 2019

BUY
$44.62 - $49.34 $81,654 - $90,292
1,830 Added 1.59%
116,850 $5.3 Million
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $1.11 Million - $1.32 Million
-24,520 Reduced 17.57%
115,020 $5.49 Million
Q4 2018

Feb 04, 2019

BUY
$48.76 - $63.23 $2.97 Million - $3.85 Million
60,860 Added 77.35%
139,540 $7.25 Million
Q3 2018

Nov 06, 2018

SELL
$55.19 - $62.25 $141,286 - $159,360
-2,560 Reduced 3.15%
78,680 $4.88 Million
Q2 2018

Aug 02, 2018

SELL
$50.53 - $62.98 $4.07 Million - $5.08 Million
-80,643 Reduced 49.82%
81,240 $4.5 Million
Q1 2018

Apr 25, 2018

SELL
$59.92 - $68.98 $1.06 Million - $1.22 Million
-17,680 Reduced 9.85%
161,883 $10.2 Million
Q4 2017

Feb 05, 2018

SELL
$59.94 - $65.35 $4.49 Million - $4.9 Million
-74,940 Reduced 29.45%
179,563 $11 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $277,806 - $320,612
5,030 Added 2.02%
254,503 $16.2 Million
Q2 2017

Jan 04, 2018

SELL
N/A
-52,597 Reduced 17.41%
249,473 $13.9 Million
Q1 2017

Jan 04, 2018

BUY
N/A
31,840 Added 11.78%
302,070 $16.4 Million
Q4 2016

Jan 04, 2018

BUY
N/A
270,230
270,230 $15.8 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sompo Asset Management Co., Ltd. Portfolio

Follow Sompo Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sompo Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sompo Asset Management Co., Ltd. with notifications on news.